2021 Revenues ($USD) : $60,450,609,227
2021 Revenues (foreign currencies) : RMB389,954,790,000
2021 R&D spend : na
2021 Number of Employees : na
Fiscal Year End : 12/31/2021
Leader : President Liu Yong

The Chinese state-owned pharmaceutical giant Sinopharm was founded in 2003. Six years later, its stock was listed on the Hong Kong stock exchange (stock code: 01099. HK). The company continues to ascend in Fortune’s Global 500 ranking. In 2013, the publication put Sinopharm in slot 446. In 2021, it pegged the company at slot 109. In addition to focusing on drug development, the company also operates a substantial China-based logistics network for drugs and medical devices. —BB